Colorectal Cancer Screening French Organizations for the Follow-up After Colonoscopy
Tempo-colo
Extending the Prerogatives of Colorectal Cancer Screening French Organizations to the Follow-up After Colonoscopy of Patients Aged 50 or More: Pilot Study in the Rhône Administrative Department
1 other identifier
interventional
33,000
1 country
1
Brief Summary
France is one of the European countries where the incidence of colorectal cancer is the highest among cancers for both sexes. Fecal occult blood screening has been implemented since 2008. However, this screening excludes high risk people who have a 10 to 30 % risk of developing a CRC during their lifetime. Colonoscopy follow up of these persons is not organized, and it is up to the attending physician to recall the date of the surveillance colonoscopy. This results in a poor compliance with the recommendations by these people. A postal reminder of the surveillance colonoscopies sent by The French screening organizations to the patients should increase adherence to follow-up recommendations. The colorectal cancer screening organizations will collects from the hepatogastroenterologists (HGE) informations on colonoscopies of people more than 50 years old who live in the Rhone. These informations will allow to send a reminder 3 months before the date recommended by the HGE. Participation rate and timeliness will be assessed, as well as the severity of the lesions found. A medico-economic analysis will also be carried out.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Aug 2017
Shorter than P25 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2017
CompletedFirst Submitted
Initial submission to the registry
December 1, 2017
CompletedFirst Posted
Study publicly available on registry
December 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedDecember 26, 2017
December 1, 2017
1.2 years
December 1, 2017
December 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
participation rate at future colonoscopy
participation rate at future colonoscopy that is the number of patient that really have colonoscopy among the patients who receive a reminder letter The systematic registry of colonoscopies will permit to assess if a patient performs it.
At time of evaluation we will check the colonoscopy realized at six months after sending the letter at the person
Secondary Outcomes (2)
description of lesions severities found at surveillance colonoscopy after letter reminder
Lesions'severity will be evaluated at 6, 9 or 15 months following the reminder sent according to the colonoscopist's recommendation (1,3 or 5 years after reference exams). By the way of systematic registration. .
Cost-utility analysis of the reminder letter for surveillance colonoscopy
Lesions'severity will be evaluated at 6, 9 or 15 months following the reminder sent according to the colonoscopist's recommendation (1,3 or 5 years after reference exams). The costs will be registered at the same time.
Study Arms (1)
Tempo Colo
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- people aged 50 years or more ;
- at high risk of colorectal cancer ;
- living in Rhône administrative departement or Metropolitan Lyon
You may not qualify if:
- person with chronic inflammatory bowel disease
- colorectal cancer in diagnosis or treatment period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Adémas-69
Lyon, Rhône, 69005, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2017
First Posted
December 26, 2017
Study Start
August 24, 2017
Primary Completion
November 1, 2018
Study Completion
December 1, 2018
Last Updated
December 26, 2017
Record last verified: 2017-12